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Tight junctions: Closing in on the seal
James Melvin Anderson and Christina M. Van Itallie
The claudins have recently been identified as a large
family of transmembrane proteins located at tight
junctions between epithelial cells; they create the
paracellular diffusion barrier and, surprisingly, may also
confer channel-like selectivity for passage of solutes
through the tissue barrier.
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In vertebrates, the movement of solutes, ions and water
through epithelial cell layers occurs both across and
between individual cells [1,2]. Both routes display cell-spe-
cific and tissue-specific variations in permeability, and
together account for the distinct transport properties of each
tissue. Studies of the hundreds of channels and transporters
on the apical and basolateral membranes of epithelial cells
have provided a detailed understanding of solute move-
ments across cells — the transcellular pathway. In contrast,
the molecular nature of the between-cell, or paracellular,
pathway has remained quite elusive. Major new insights
into this pathway have come within the last year, following
the identification of the claudin protein family of tight junc-
tion proteins [3–6]. Sixteen distinct claudins — from the
Latin claudere, to close — have so far been identified, which
differ in their expression patterns. The phenotype of an
inherited human disorder associated with a defect in para-
cellin-1 (claudin-16) strongly suggests that claudins might
form ion-selective and solute-selective channels through
tight junctions [7]. If this prediction is true, we may soon be
able to explain the variable properties of paracellular trans-
port and perhaps gain a better understanding of acquired
and inherited diseases of epithelial barriers. 
The paracellular epithelial barrier is formed by a
continuous intercellular contact called the tight junction.
First visualised by electron microscopy in the early 1960s,
the paracellular barrier appears as a region of very close
cell-to-cell apposition at the apical end of the lateral
membrane domain (Figure 1). Using the freeze-fracture
electron microscopy technique, the contacts appear to be
formed by linear rows or polymers of transmembrane
proteins, which contact similar rows on adjacent cells and
seal the intercellular space. Over the past decade, numer-
ous peripheral membrane proteins have been identified
that are associated with the cytoplasmic surface of the
junction. Unfortunately, these have shed little light on
how the barrier is formed and why it varies among cell
types in its electrical tightness and selectivity for solute
size and charge (reviewed in [1,2]).
The first candidate for being a paracellular-barrier-
forming protein was occludin, a four-span transmembrane
protein located specifically within tight junction fibrils
(Figure 1) [8]. Occludin clearly has some functional role in
creating the barrier, as transepithelial electrical resistance
is increased when occludin is over-expressed in cultured
epithelial cell lines (MDCK cells) [9,10]. Furthermore,
occludin is an intercellular adhesion molecule [11] and
peptides corresponding to extracellular regions of occludin
were found to reduce the electrical barrier when added to
cultured epithelia monolayers [12]. Until last year, it
seemed that occludin was the main component of the
barrier and formed continuous adhesive contacts to seal
the paracellular space. Several recent observations have
suggested this is not the whole story. First, there is only
one occludin gene, and the protein is expressed in essen-
tially all tight junctions; so occludin is unlikely to account
for tissue differences in barrier properties. Second, and
more compelling, was the observation that embryonic
stem cells from which occludin was removed by homolo-
gous recombination still showed linear fibrils in freeze-
fracture electron microscopy images and were still capable
of forming an intercellular barrier [13].
Important new insights into how the intercellular barrier is
formed have come from a remarkable series of papers from
Tsukita’s group, beginning with the identification of
claudin-1 and claudin-2 in 1998 [3]. Claudins are small
transmembrane proteins, about 20–22 kDa, which span the
membrane four times; by immuno-electron microscopy,
they are located within the continuous linear fibrils of the
tight junction. The intrinsic ability of claudins to form the
linear fibrils was revealed when they were expressed in
fibroblasts, which do not normally produce claudin and
occludin or make tight junctions [3]. The expression of
claudin-1 or claudin-2 from transgenes in these cells was
found to result in extensive fibril formation, while expres-
sion of occludin gave rise to only short, rudimentary fibrils.
When coexpressed, occludin is recruited into the more
robust fibrils formed by claudin [3]. Finally, claudins were
shown to confer significantly higher cell–cell adhesiveness
than occludin, giving rise to the idea they are the primary
force organising the fibrils [14].
What is the experimental evidence that claudins actually
create the tight junction’s physiological barrier? The best
support for this has come from the action of a bacterial
enterotoxin, CPE, produced by Clostridium perfringens,
which binds to claudin-3 and claudin-4 [15]. The so-
called CPE receptor, which turns out to be claudin-4, was
actually cloned and studied before the claudin family was
discovered and the receptor shown to be a tight junction
protein. The full-length 35 kDa toxin binds to either
claudin-3 or claudin-4 and induces cytotoxicity through
an incompletely understood mechanism; a small carboxy-
terminal fragment of the toxin binds to the claudins with
high affinity but is not cytotoxic. Sonoda et al. [15]
showed that prolonged exposure of cultured MDCK cells
to the non-cytotoxic CPE fragment caused selective
removal and degradation of claudin-4 from the junction,
simplification of the freeze-fracture fibrils and a dose-
dependent disruption of the paracellular barrier. In con-
trast, claudin-1, which is also produced by MDCK cells,
was unaffected by the non-cytotoxic CPE fragment, at
least as determined by immunolocalization at the light
microscopy level.
Will the claudins provide the explanation for why the
paracellular barrier differs among cell types and tissues?
To do this, they should be a large protein family and
show differential expression patterns; early data imply
they fulfil both criteria. To date, sixteen claudins have
been identified in several vertebrate species. Interest-
ingly, none has been found in invertebrates, which appear
to form epithelial barriers in a fundamentally different
way. The limited work already done has shown that some
of the claudins have highly restricted expression patterns.
For example, claudin-5 has been found only in endothe-
lial cells, and in some tissues it is even further restricted
to arteries and excluded from veins [5]. This observation
suggests a basic molecular difference between the barri-
ers of blood vessels and epithelial cells, perhaps related to
the fact that immune cells have to migrate across blood
vessel walls into infected or inflamed tissues. Claudin-11
is found only in the tight junctions of Sertoli cells in the
testis and in the myelin sheaths of oligodendrocytes in
the brain [6]. It has long been known that accessory cells
in the nervous system wrap around axons to isolate their
ionic environment and accelerate electrical transmission.
We now know these seals are a curiously organised form
of tight junction. 
A spectacular insight into the function of claudins was
provided by the discovery that mutations in the gene for
paracellin-1 (claudin-16) are the cause of a rare human
renal magnesium-wasting syndrome [7]. Paracellin-1 is
found predominately in the thick ascending loop of
Henle, a tubule segment where the divalent cations
magnesium and calcium are resorbed from the tubule,
exclusively through a paracellular route and driven by the
intraluminal positive electrical potential. When para-
cellin-1 is absent, magnesium does not exit the tubule
but is lost in the urine, and this leads to hypomagne-
saemia and seizures [7]. The clinical phenotype is reces-
sive, so both copies of the normal paracellin gene must be
absent for paracellular passage of magnesium to fail. The
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Cross-section of a distal tubule from the rat kidney. (a) A diagram
highlighting the distinction between the transcellular and paracellular
pathways for movement of water and solutes across the tubule
epithelium. The three photomicrographs show: (b) immunolocalization
of occludin (green); (c) immunolocalization of claudin-1 (red); and
(d) merged images, revealing the colocalization of both proteins
(yellow) at the tight junctions, where they regulate paracellular
transport. Nuclei are stained blue with DAPI in (d).
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most obvious interpretation of these results is that para-
cellin-1 functions as a magnesium-selective channel
through the tight junction barrier. This is not such a
radical idea if we refer back to the physiology literature of
the 1950s to 1970s [1], but has probably been ignored for
lack of a rational molecular explanation. Of note, a
chronic form of interstitial nephritis in cattle was recently
shown to result from mutation of the claudin-16 gene (Y.
Sugimoto, personal communication) although the patho-
physiological mechanism has yet to be reported. 
Where is research on paracellular transport headed?
Much work needs to be done to verify that claudins
confer differential channel properties on tight junctions.
The evidence should come from a combination of muta-
genesis, targeted gene inactivation and transgenic animal
approaches. The variable chemistry of the extracellular
loops of the claudins suggests a way that channels with
different specificities could be formed. These experi-
mental approaches will probably be complemented by
the discovery of genetic variation in claudins that predis-
poses individuals to disease or altered epithelial transport
function. Given the fundamental role of tight junctions
in forming tissue barriers, we can predict the discovery of
genetic variation affecting drug absorption and perhaps
even transepithelial movement of microbes and antigens.
It remains to be determined whether claudins form
homotypic or heterotypic oligomers, and whether differ-
ent combinations create different channel properties.
Despite the recent focus on claudins, the contribution of
occludin to the barrier remains unresolved and should
not be ignored. A final practical goal will be pharmaco-
logical manipulation of claudins and the tight junction
barrier in order to alter the transport properties within
specific organs for therapeutic purposes. 
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